acetylglucosamine has been researched along with Parkinson Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davey, AK; Kassiou, M; Mellick, GD; Rudrawar, S; Ryan, P; Xu, MM | 1 |
| Galesic, A; Pratt, MR | 1 |
| Hanover, JA; Jeong, H; Kim, BG; Kim, HB; Kim, HJ; Kim, HY; Kim, JI; Kwon, T; Lee, BE; Lee, HE; Lee, J; Lee, SE; Myung, K; Suh, PG; Yang, YR; Yi, EC | 1 |
| Balana, AT; Pratt, MR | 1 |
| Balana, A; De Leon, CA; Galesic, A; Levine, PM; Lewis, YE; Marotta, NP; Pratt, MR | 1 |
| Hao, J; He, Y; Li, H; Ma, X | 1 |
| Kalia, LV; Kalia, SK; O'Hara, DM | 1 |
| Balana, AT; De Leon, CA; Galesic, A; Lashuel, HA; Levine, PM; Mahul-Mellier, AL; Navarro, MX; Pratt, MR | 1 |
| Groves, JA; Lee, A; Yildirir, G; Zachara, NE | 1 |
| Ambroso, MR; Arnold, DB; Langen, R; Lewis, YE; Lin, YH; Marotta, NP; Pratt, MR; Roth, MT; Zaro, BW | 1 |
3 review(s) available for acetylglucosamine and Parkinson Disease
| Article | Year |
|---|---|
Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders.
Topics: Acetylglucosamine; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Parkinson Disease; Protein Processing, Post-Translational; tau Proteins | 2021 |
The emerging link between O-GlcNAcylation and neurological disorders.
Topics: Acetylglucosamine; Acetylglucosaminidase; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; N-Acetylglucosaminyltransferases; Nervous System Diseases; Neurons; Parkinson Disease; Protein Processing, Post-Translational; Proteins | 2017 |
Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease.
Topics: Acetylglucosamine; Adrenergic beta-Agonists; alpha-Synuclein; Animals; Gastrointestinal Microbiome; Humans; Parkinson Disease | 2018 |
7 other study(ies) available for acetylglucosamine and Parkinson Disease
| Article | Year |
|---|---|
O-GlcNAcylation of truncated NAC segment alters peptide-dependent effects on α-synuclein aggregation.
Topics: Acetylglucosamine; alpha-Synuclein; Carbohydrate Conformation; Dose-Response Relationship, Drug; Glycosylation; Humans; Parkinson Disease; Protein Aggregates; Structure-Activity Relationship | 2020 |
Investigating the Effects of O-GlcNAc Modifications in Parkinson's Disease Using Semisynthetic α-Synuclein.
Topics: Acetylglucosamine; alpha-Synuclein; Cysteine; Escherichia coli; Esters; Gene Expression; Glycosylation; Humans; Parkinson Disease; Peptide Biosynthesis; Peptides; Plasmids; Protein Engineering; Recombinant Proteins; Solid-Phase Synthesis Techniques; Sulfhydryl Compounds; Threonine | 2020 |
O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease.
Topics: Acetylglucosamine; Animals; Behavior, Animal; Cell Survival; Dopaminergic Neurons; Electrophysiological Phenomena; Female; Immunohistochemistry; Male; Mice; Movement Disorders; Neurodegenerative Diseases; Optogenetics; Parkinson Disease; Protein Modification, Translational; Synapses; Up-Regulation | 2020 |
O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein.
Topics: Acetylglucosamine; alpha-Synuclein; Calpain; Escherichia coli; Humans; Parkinson Disease; Peptides; Protein Processing, Post-Translational; Proteolysis; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization | 2017 |
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
Topics: Acetylglucosamine; Acylation; alpha-Synuclein; Animals; Cells, Cultured; Female; Mice; Mice, Inbred C57BL; Parkinson Disease; Pregnancy; Protein Aggregation, Pathological; Protein Processing, Post-Translational | 2019 |
Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.
Topics: Acetylglucosamine; Alzheimer Disease; Animals; beta-N-Acetylhexosaminidases; Calcium; Heat-Shock Proteins; Humans; Mitochondria; N-Acetylglucosaminyltransferases; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction | 2013 |
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.
Topics: Acetylglucosamine; Acylation; alpha-Synuclein; Humans; Parkinson Disease | 2015 |